Volume 57, Issue 38 pp. 12499-12503
Communication

Bioinspired Artificial Nanodecoys for Hepatitis B Virus

Dr. Xuan Liu

Dr. Xuan Liu

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, 361102 China

These authors contributed equally to this work.

Search for more papers by this author
Dr. Lunzhi Yuan

Dr. Lunzhi Yuan

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Public Health and School of Life Science, Xiamen University, 361102 China

These authors contributed equally to this work.

Search for more papers by this author
Liang Zhang

Liang Zhang

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Public Health and School of Life Science, Xiamen University, 361102 China

Search for more papers by this author
Yalin Mu

Yalin Mu

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, 361102 China

Search for more papers by this author
Xiaoling Li

Xiaoling Li

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Public Health and School of Life Science, Xiamen University, 361102 China

Search for more papers by this author
Dr. Chao Liu

Dr. Chao Liu

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, 361102 China

Search for more papers by this author
Dr. Peng Lv

Dr. Peng Lv

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, 361102 China

Search for more papers by this author
Dr. Yali Zhang

Dr. Yali Zhang

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Public Health and School of Life Science, Xiamen University, 361102 China

Search for more papers by this author
Prof. Tong Cheng

Prof. Tong Cheng

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Public Health and School of Life Science, Xiamen University, 361102 China

Search for more papers by this author
Prof. Quan Yuan

Corresponding Author

Prof. Quan Yuan

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Public Health and School of Life Science, Xiamen University, 361102 China

Search for more papers by this author
Prof. Ningshao Xia

Prof. Ningshao Xia

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Public Health and School of Life Science, Xiamen University, 361102 China

Search for more papers by this author
Dr. Xiaoyuan Chen

Dr. Xiaoyuan Chen

Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, MD 20892 USA

Search for more papers by this author
Prof. Gang Liu

Corresponding Author

Prof. Gang Liu

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, 361102 China

State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Biology, Xiamen University, 361102 China

Search for more papers by this author
First published: 08 August 2018
Citations: 53

Graphical Abstract

Hitting hepatitis: A facile and bioinspired strategy is presented for fabricating a class of nanomimics that over-express Hepatitis B virus (HBV) receptor by a natural biosynthetic procedure to act against HBV infection.

Abstract

A facile route is presented for fabricating a new class of nanomimics that overexpress hepatitis B virus (HBV) receptor by a natural biosynthetic procedure against HBV infection. A nine-transmembrane HBV-specific receptor, human sodium taurocholate co-transporting polypeptide (hNTCP), was engineered to naturally immobilize it onto the cellular surface and subsequently trigger the budding of hNTCP-anchoring membrane vesicles (hNTCP-MVs) that favor the HBV virion. hNTCP-MVs could rapidly block HBV infection in cell models. Furthermore, hNTCP-MVs treatment could effectively prevent viral infection, spreading, and replication in a human-liver-chimeric mouse model of HBV infection. Our findings demonstrate the receptor-mediated antiviral effect of hNTCP-MVs to trick HBV and offer novel opportunities for further development of antiviral strategies in nanomedicine.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.